US Court Sides With Amneal On ProAir Patents As Teva Vows Appeal
Teva Attempted To Dismiss Ten Of Amneal’s Counterclaim Counts
The inhaler patent saga goes on. A US District Court orders Teva to either de-list or correct patents for its inhaler ProAir HFA, but the originator disagrees and gets ready to appeal.
